← SynDRA
NU-6027
SynDRA canonical compound SYN0062398 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ATR | CCNA2 | CDK1 | CDK2 |
| Mechanism of action | CDK inhibitor |
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
Cross-references
Synonyms
- NU6027
- RefChem:542029
- 6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine
- 2,6-diamino-4-cyclohexylmethoxy-5-nitrosopyrimidine
- 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE
- 6-(cyclohexylmethoxy)-5-nitroso-pyrimidine-2,4-diamine
- 6-(Cyclohexylmethoxy)-5-nitroso-2,4-pyrimidinediamine
- SMR000568410
- pyrimidine deriv.
- DGWXOLHKVGDQLN-UHFFFAOYSA-N
- MFCD05664735
- 2,4-Pyrimidinediamine, 6-(cyclohexylmethoxy)-5-nitroso-
- 1e1x
- MLS001074890
- MLS006011251
- BDBM5566
- orb1300616
- SCHEMBL6260430
- SCHEMBL29644996
- GLXC-21293
- HMS2234C12
- HMS3263D06
- HMS3373H16
- HMS3653A07
- EX-A5011
- VIA03608
- Tox21_501212
- NSC707616
- NSC756874
- s7114
- AKOS032945135
- CCG-265018
- LP01212
- NSC-707616
- NSC-756874
- NU6027?
- SDCCGSBI-0633805.P001
- NCGC00165844-01
- NCGC00165844-02
Look up NU-6027 in the interactive SynDRA portal →